ONMD Stock Risk & Deep Value Analysis

Onemednet Corp

Healthcare • Health Information Services

DVR Score

1.0

out of 10

Distressed

What You Need to Know About ONMD Stock

We analyzed Onemednet Corp using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran ONMD through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.

Updated Mar 9, 2026•Run Fresh Analysis →

How Risky Is ONMD Stock?

Overall Risk

Aggressive

Financial Risk

High

Market Risk

Medium

Competitive Risk

High

Execution Risk

High

Regulatory Risk

Medium

What Are the Red Flags for ONMD?

  • âš 

    Failure to secure additional financing, leading to liquidity crisis or bankruptcy

  • âš 

    Further equity dilution at depressed valuations

  • âš 

    Continued negative earnings and widening losses in Q1 2026 report

  • âš 

    Increased competitive pressure from larger, better-funded incumbents or new entrants

Unlock ONMD Red Flags & Risk Warnings

Create a free account to see the full analysis

What Does Onemednet Corp (ONMD) Do?

Market Cap

$64.97M

Sector

Healthcare

Industry

Health Information Services

Employees

22

OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East. The company offers iRWD, which provides regulatory grade imaging and clinical data in the pharmaceutical, device manufacturing, contract research organizations, and artificial intelligence markets markets; and BEAM, a medical imaging exchange platform between hospital/healthcare systems, imaging centers, physicians, and patients. OneMedNet Corporation is headquartered in Eden Prairie, Minnesota.

Visit Onemednet Corp Website

Is ONMD Stock Undervalued?

Onemednet Corp continues to operate in the compelling real-world data (RWD) and imaging RWD (iRWDâ„¢) market, presenting a long-term strategic vision within a high-growth sector. This theoretical market opportunity remains the sole contributor to its minimal score. However, as of 2026-03-09, no material positive changes have been observed since the prior analysis on 2026-02-23. The company still exhibits profound financial instability, including critically high cash burn, minimal to negative revenue growth, and an unsustainable financial trajectory. The lack of a clear, executable path to profitability and ongoing severe dilution risks continue to overshadow any strategic potential. The probability of achieving 10x growth remains exceptionally low due to these persistent and critical financial red flags, making it a highly precarious and speculative investment. The score remains consistent with the previous analysis given the absence of any fundamental shifts.

Unlock the full AI analysis for ONMD

Get the complete DVR score, risk analysis, and more

Does ONMD Have a Competitive Moat?

Sign in to unlock

Moat Rating

⚪ None

Moat Trend

Eroding

Moat Sources

2 Identified

Intangible Assets/IP (nascent and unproven unique data processing algorithms)Switching Costs (potentially, if embedded deeply into clinical workflows, but unproven at scale)

The company's nascent 'moat' is extremely fragile and easily replicated or surpassed by larger, better-funded competitors with superior resources, technology, and sales channels. Without significant scale and proven differentiation, any potential advantage is ephemeral.

Moat Erosion Risks

  • •Inability to achieve sufficient scale to create network effects or meaningful switching costs
  • •Competitors developing superior or cheaper iRWD solutions
  • •Lack of funding to invest in IP protection and R&D

ONMD Competitive Moat Analysis

Sign up to see competitive advantages

What Could Drive ONMD Stock Higher?

Near-Term (0-6 months)

  • •Q1 2026 Earnings Report (estimated early May 2026)
  • •Announcement of a new, small-scale pilot project or partnership

Medium-Term (6-18 months)

  • •Securing a significant institutional funding round (critical for survival)
  • •Demonstrated acceleration in iRWD platform adoption or data licensing agreements
  • •Strategic partnership with a major pharmaceutical or life sciences company

Long-Term (18+ months)

  • •Widespread industry adoption of iRWD as a standard for drug development and clinical trials
  • •Achieving a sustainable, profitable business model and positive cash flow
  • •Expansion of regulatory acceptance for RWD/iRWD in drug approvals

Catalysts & Growth Drivers

Upgrade to Premium to see catalysts

What's the Bull Case for ONMD?

  • ✓

    Confirmation of a significant, non-dilutive financing round (e.g., strategic investment from a major pharma partner)

  • ✓

    Quarterly revenue growth exceeding 50% year-over-year for at least two consecutive quarters

  • ✓

    Demonstrable progress towards positive operating cash flow and reduced cash burn

  • ✓

    Announcement of multiple new, high-value data partnerships or customer contracts

Bull Case Analysis

See what could go right with Premium

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for ONMD (Onemednet Corp) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.

More Resources to Boost Your Portfolio

Explore our other guides and tools to maximize your investment returns

5-Minute Guide Thumbnail

6 Simple Steps Spotting Undervalued Stocks

Learn More
Dividend Stocks Thumbnail

Earn $500/Month with Dividend Stocks

Learn More
Swing Trading Guide Thumbnail

3 Swing Trading Strategies for Predictable Gains

Learn More
Navigated to ONMD Stock Risk & Deep Value Analysis